PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
about
Pharmacological Rescue of Long-Term Potentiation in Alzheimer Diseased SynapsesPeripheral Interventions Enhancing Brain Glutamate Homeostasis Relieve Amyloid β- and TNFα- Mediated Synaptic Plasticity Disruption in the Rat Hippocampus.A novel synthetic phosphodiesterase 5 inhibitor, KJH-1002, ameliorates scopolamine-induced cognitive impairments in mice by activating the cGMP/CREB signaling pathway and attenuating oxidative damage.
P2860
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
@en
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease.
@nl
type
label
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
@en
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease.
@nl
prefLabel
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
@en
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease.
@nl
P2093
P2860
P356
P1476
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
@en
P2093
Andrew F Teich
Cameron Holman
Faisal Saeed
Mikako Sakurai
Mitesh Patel
P2860
P304
P356
10.3233/JAD-151104
P577
2016-03-09T00:00:00Z